logo
  

Quest Diagnostics Inc. (DGX) Sank To A 1-Month Low On Weak Q3 Forecast

Quest Diagnostics Inc. (DGX) announced Thursday morning that it now expects to report third quarter adjusted earnings per share from continuing operations of $1.02. The consensus estimate is for EPS of $1.20.

Quest Diagnostics gapped open sharply lower Thursday, but was range-bound throughout the session. The stock closed down by 3.04 at $58.66 on the highest volume of the year. Quest Diagnostics dropped to over a 1-month low and fell below both its 50 and 200-day moving averages.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT